An Uncomfortable Discussion about Supply Chain Fragility in Pharma
How many years has the pharmaceutical industry been talking about supply chain fragility?
GET YOUR COPY OF THE DOWNLOAD
Despite remarkable pharmacological and medical scientific advancements, the pharma supply chain’s robustness has not advanced meaningfully. It’s time to address the elephant in the room.
For years, the pharma industry and individual manufacturers alike have professed the need to improve the supply chain, and yet little transformative progress has been made. If the pandemic has not taught all of us the critical nature of pharma supply chain transformation, nothing will. But in order to get there, there are steps individual companies can take as well as considerations for the industry as a whole.